Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo — Stella

Home/Recurrent Urinary Tract Infection/Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo

View on ClinicalTrials.gov

Recruiting

Back to Recurrent Urinary Tract Infection trials

Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Maimonides Medical Center, Brooklyn, New York

Key details

Phase

Post-approval study

Sponsor

Maimonides Medical Center

Collaborators

American Urological Association

Enrollment target

~100 participants

Started

November 2020

Primary completion

August 2026

Age range

60 Years – 90 Years

Sex

Female only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.